FTFinancial Times·3hBusiness
score+0.00
AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough
Original
AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough
“The headline uses a play on words regarding corporate scale, but the summary frames the discussion as a neutral analysis of financial strategy.”